SEC Filing Details

Document Details

Filing Date
September 8, 2026
Document Date
September 8, 2026
Form Description
EFFECT
Filing Group
Other
Company
BridgeBio Oncology Therapeutics
Issuer
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.